<DOC>
	<DOCNO>NCT00121901</DOCNO>
	<brief_summary>Post-ERCP pancreatitis serious complication ERCP . Two study show promising preventive effect glyceryl nitrate . This study provide final answer clinical question : Does glyceryl nitrate prevent post-ERCP pancreatitis ? The study prospective , randomize , double blind , placebo-controlled multicenter trial . The investigator intend include 1600 patient Norway , Sweden , Denmark , France . The patient receive either placebo glyceryl nitrate patch ( 15 mg/24 hour ) . Follow-up occur 7 day . The primary outcome measure post-ERCP pancreatitis , secondary outcome measure mild , moderate severe pancreatitis ; post procedure pancreatitis-related mortality ; adverse event .</brief_summary>
	<brief_title>Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography ( ERCP ) Pancreatitis ?</brief_title>
	<detailed_description>Project : This study compare glyceryl nitrate ( GN ) treatment non-active treatment prevention post-ERCP acute pancreatitis , inflammation pancreas occur procedure know ERCP . Background : ERCP ( endoscopic retrograde cholangiopancreaticography ) examination pancreas possible perform therapeutic measure stone removal common bile duct visualisation pancreas . Inflammation pancreas ERCP procedure ( call : post-ERCP pancreatitis ) fear common complication ERCP . It occur 1-40 % patient , rate 5 % typical . Currently , background post-ERCP pancreatitis poorly know . Attempts prevent post-ERCP pancreatitis carry change low-risk technique , avoid high-risk patient , use pharmacological prophylaxis . Glyceryl Nitrate : Glyceryl nitrate well-known medicine use many year disease . Possible side effect headache low blood pressure . Other side effect dizziness , tiredness , nausea , local redness application site allergic reaction skin rare . Aim : The purpose study document pre-treatment GN effective prevent post-ERCP pancreatitis . In two early GN study , sample size relatively small ( less one hundred ) rate post-ERCP pancreatitis control group quite high ( 15-17 % ) . Therefore , study need confirm promise effect GN prophylaxis post-ERCP pancreatitis . Participants : The study include every patient undergo ERCP age 18 year . Patients exclude active acute pancreatitis , previous sphincterotomy ( cut sphincter end biliary pancreatic duct duodenum ) chronic pancreatitis calcification . Also , patient may take sildenafil ( Viagra ) GN take together sildenafil . Patients allergic glyceryl nitrate glue include . Patients constrictive pericarditis ( inflammation fibrosis sack around heart ) ; pericardial tamponade ( blood liquor sack around heart ) ; low blood pressure ; aortic stenosis ( stenosis aortic valve ) ; hypertrophic obstructive cardiomyopathy ( special disease thickness heart ) ; mitral stenosis ( stenosis mitral valve ) ; anemia ( low hemoglobin ) ; untreated hypothyroidism ( thyroid disease ) exclude disease glyceryl nitrate use . Pregnant woman exclude . Patients include . Practical : Patients prepare study normal procedure . Prior procedure , patient ask participate study . If patient accept , oral write consent , receive either GN patch non-active patch chestwall 40-60 minute prior ERCP procedure . A canula insert cubital vein medication . The ERCP initiate , patient observe afterwards accord local practice , typically 3 hour . Patients ask fill letter question relate symptom pancreatitis ( pain , fever , nausea , vomit , hospitalization ) send investigate center 7 day . If patient send letter contact phone within 14 day . Interim analysis : An interim analysis make , 800 patient include . The study stop , 1 ) interim analysis show significant high mortality one group 2 ) study proceed 2 year . Economy : The project multicenter trial European Post-ERCP Pancreatitis Preventing Study Group . This local project locate XX-department . No commercial interest involve . The investigators/authors work free authorship . Finances seek fund research . References : 1 . Freeman M. Post-ERCP pancreatitis : patient technique-related risk factor . JOP 2002 ; 3 ( 6 ) :169-176 . 2 . Demols A , Deviere J . New frontier pharmacological prevention post-ERCP pancreatitis : cytokine . JOP 2003 ; 4 ( 1 ) :49-57 . 3 . Testoni P. Preventing post-ERCP pancreatitis : ? . JOP 2003 ; 4 ( 1 ) :22-32 . 4 . Mariani A. Pharmacological prevention post-ERCP pancreatitis : therapy best ? . JOP 2003 ; 4 ( 1 ) :68-74 . 5 . Murray B , Carter R et al . Diclofenac reduce incidence acute pancreatitis endoscopic retrograde cholangiopancreatography . Gastroenterology 2003 ; 124:1786-1791 . 6 . Sand J , Nordback I . Prospective randomize trial effect nifedipine pancreatic irritation endoscopic retrograde cholangiopancreatography . Digestion 1993 ; 54:105-11 . 7 . Sudhindran S , Bromwich E et al . Prospective randomize double-blind placebo-controlled trial glyceryl trinitrate endoscopic retrograde cholangiopancreaticography-induced pancreatitis . British J Surg 2001 ; 88:1178-1182 . 8 . Moreto M , Zaballa M. et al . Transdermal glyceryl trinitrate prevention post-ERCP pancreatitis : randomize double-blind trial . Gastrointest Endoscopy 2003 ; 57:1-7 . 9 . Harrison et al . Bioequivalence comparison two drug-in-adhesive transdermal nitroglycerine patch . Am J Ther 1996 ; 3:580-585 . 10 . Pande H , Thuluvath PJ . Pharmacological prevention post-endoscopic retrograde cholangiopancreatography pancreatitis . Drugs 2003 ; 63 ( 17 ) :1799-1812 . 11 . Freeman ML . Prevention post-ERCP pancreatitis : Pharmacologic solution patient selection pancreatic stent ? Gastroenterology 2003 ; 124 ( 7 ) :1977-1980 . 12 . Cotton PB , Lehman G , Vennes J , Geenen JE , et al . Endoscopic sphincterotomy complication management : attempt consensus . Gastrointest Endosc 1991 ; 37:383-393 .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<criteria>All patient ( men woman ) 18 year old go ERCP procedure perform different center September 1 , 2004 January 31 , 2005 include . Before study : active acute pancreatitis ( define : acute upper abdominal pain Samylases x 3 upper normal limit OR upper abdominal pain + radiological finding [ CAT/MRscan ] consistent acute pancreatitis OR pathoanatomical finding consistent acute pancreatitis surgery ) Known previous sphincterotomy Chronic pancreatitis know calcification Hypotension ( definition : systolic blood pressure &lt; 100 mmHg ) Anemia , men/women ( hemoglobin &lt; 6 mmol/l &lt; 9.7 g/dl ) Constrictive pericarditis Pericardial tamponade Hypertrophic obstructive cardiomyopathy , aortic stenosis Mitral stenosis sildenafil within 24 hour ERCP procedure 24 hour procedure Hypersensibility nitroglycerine Hypersensibility apply glue patch Known untreated hypothyroidism Pregnancy potential become pregnant , i.e . use safe contraception ( intrauterine device [ IUD ] oral contraception ) Included earlier study Exchange stent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Pancreatitis</keyword>
	<keyword>Cholangiopancreatograpy , Endoscopic Retrograde/adverse</keyword>
	<keyword>Nitroglycerin</keyword>
	<keyword>Randomized Controlled Trial ,</keyword>
</DOC>